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Advanced atherosclerosis in predialysis patients with chronic population, dialysis patients have more than a 10 times
renal failure. higher relative risk for cardiovascular mortality [1]. Lind-
Background. Atherosclerosis is advanced in hemodialysis
ner et al pointed out this fact in their early work, andpatients as shown by increased intima-media thickness of ca-
rotid arteries (CA-IMT), although it is not established whether they thought that atherosclerosis was accelerated in long-
the advanced atherosclerosis results from hemodialysis treat- term maintenance hemodialysis [2]. Our previous studies
ment or from chronic renal failure. The purpose of this study revealed that hemodialysis patients had advanced arte-was to evaluate the effects of hemodialysis and renal failure
rial wall changes as shown by increased intima-mediaon CA-IMT in patients with chronic renal failure.
Methods. CA-IMT was measured by high-resolution B-mode thickness (IMT) of the carotid and femoral arteries as
ultrasonography in 110 patients with chronic renal failure be- an index of thickening of arterial wall [3, 4]. Also, arterialfore starting dialysis (CRF group), and compared with CA-IMT
wall stiffness is increased in hemodialysis patients asof 345 hemodialysis patients (HD group) and 302 healthy con-
trol subjects. They were all nondiabetic and the three groups demonstrated by increased aortic pulse wave velocity
were comparable in age and gender. [5, 6]. These arterial wall changes are significant pre-
Results. As compared with the healthy control subjects, the
dictors of cardiovascular mortality in nonuremic popula-CRF and HD groups had greater CA-IMTs, whereas CA-IMTs
of the CRF and HD groups were not statistically different. There tions [7, 8] and in hemodialysis patients [9, 10]. However,
was no significant correlation between duration of hemodialysis it is not established whether atherosclerosis is acceler-
and CA-IMT in the HD group. Multiple regression analysis in
ated by hemodialysis. Although some authors reportedthe total subjects indicated that presence of renal failure, but
that carotid artery IMT (CA-IMT) correlated positivelynot being treated with hemodialysis, was a significant factor
associated with increased CA-IMT independent of age, gender, with duration of hemodialysis treatment [11–13], others
blood pressure, smoking, high-density lipoprotein (HDL) and failed to confirm such a significant relationship of dura-non-HDL cholesterol levels.
tion of hemodialysis with CA-IMT [3, 14–16], with aorticConclusions. These results demonstrate that thickening of
arterial wall is present in patients with chronic renal failure be- pulse wave velocity [5, 6], or with histological grading
fore starting hemodialysis treatment, and support the concept of arteries [17]. According to Joki et al, significant steno-that advanced atherosclerosis in hemodialysis patients is due
sis of coronary arteries is frequently found in patientsnot to hemodialysis treatment, but to renal failure and/or meta-
bolic abnormalities secondary to renal failure. at the time of starting hemodialysis [18].
To examine the possibility that atherosclerosis is ad-
vanced before the patient begins hemodialysis treatment,
The risk of cardiovascular death is substantially ele- we measured CA-IMT in 110 predialysis patients with
vated in patients with end-stage renal disease who are
chronic renal failure, 345 patients on maintenance hemo-treated with hemodialysis. As compared with the general
dialysis and 302 healthy control subjects. The results
demonstrated that CA-IMT of the predialysis patients
Key words: carotid artery, intima-media thickness, renal failure, hemo-
was as great as that of the maintenance hemodialysisdialysis, end-stage renal disease, cardiovascular disease.
patients, suggesting that it is not hemodialysis itself, but
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Table 1. Subjects
Healthy CRF Hemodialysis P value
Number 302 110 345 —
Male:female 147:155 65:45 189:156 0.114
Age years 57.80.5 59.41.0 58.30.5 0.352
Serum creatinine lmol/L 652 56443a 100314a,b 0.0001
Smoking index cigarette-year 29429 39251 29424 0.180
Systolic BP mm Hg 1261 1443a 1421a 0.0001
Diastolic BP mm Hg 761 791 681a,b 0.0001
BMI kg/m2 22.60.2 22.30.4 21.60.2b 0.0002
Glucose mmol/L 5.320.03 5.280.10 4.980.05a,b 0.0001
Total cholesterol mmol/L 5.130.05 4.510.13a 4.570.06a 0.0001
HDL-C mmol/L 1.480.03 1.180.04a 1.240.02a 0.0001
NonHDL-C mmol/L 3.660.05 3.330.14a 3.340.06a 0.0001
Triglycerides mmol/L 1.330.05 1.420.07 1.500.04a 0.023
Duration of HD months — — 884 —
Data are mean  standard error (SE). P values are by analysis of variance (ANOVA) and by the chi-square test. Abbreviations are: CRF, chronic renal failure;
BP, blood pressure; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; NonHDL-C, non-high-density lipoprotein cholesterol; HD, hemodialysis.
a P  0.05 vs. healthy control subjects, and b P  0.05 vs. HD group by Scheffe-type multiple comparison
METHODS the HD patients were chronic glomerulonephritis (78%),
polycystic disease (6%), lupus nephritis (4%), hyperten-Subjects
sive nephrosclerosis (4%), toxemia of pregnancy (3%),This study consisted of 757 nondiabetic subjects in-
chronic pyelonephritis (2%), and unknown (3%). Medi-cluding 110 predialysis patients with chronic renal failure
cation for hypertension included CCB (47%), ACEI(CRF group), 345 patients with end-stage renal disease
(20%), -, - or -blockers (3%), and loop diureticstreated with maintenance hemodialysis (HD group), and
(28%). Overall, 62% of the HD patients were treated302 healthy control subjects who gave informed consent.
with antihypertensive medication. Also, 4% of the HDThese subjects were randomly selected from our data-
patients were receiving statins for dyslipidemia. No pa-base after categorization by age range and gender, so
tient was receiving steroids. The patients were studiedthat the three groups were comparable in terms of age
without washing out these medications.and gender. Clinical characteristics of the subjects were
The healthy controls were participants of a healthgiven in Table 1. This study was approved by the insti-
check program in Osaka City. The exclusion criteria fortutional ethical committee (Inoue Hospital Approval
the healthy control subjects were fasting hyperglycemiaNo. 103).
as defined by fasting plasma glucose 7.0 mmol/LPatients in the CRF group had an increased serum cre-
(126 mg/dL), overt proteinuria, and liver dysfunction asatinine level greater than 133 mol/L (1.5 mg/dL). The
defined by increased serum ALT 50 IU. Also, we ex-primary renal diseases of the CRF group were chronic
cluded those who were on medication for diabetes melli-glomerulonephritis (70%), hypertensive nephrosclerosis
tus, hypertension, and/or hyperlipidemia. Therefore, the(9%), polycystic disease (4%), toxemia of pregnancy
healthy control subjects included those who were hyper-(1%), and unknown (16%). Medication for hypertension
tensive and/or hyperlipidemic without medication.included calcium channel blockers (CCB; 57%), angio-
tensin-converting enzyme inhibitors (ACEI; 14%), -, -
Measurement of CA-IMTor -receptor antagonists (29%), and loop diuretics
Carotid artery intima-media thickness (CA-IMT) was(36%). Overall, 68% of the CRF patients received anti-
measured by high-resolution B-mode ultrasonographyhypertensive medication. Also, statins were used for
using a real-time ultrasonograph with a 10-MHz in-line18% of the CRF patients for dyslipidemia. No patient
Sectascanner (SSD 650 CL; Aloka Co. Ltd., Tokyo, Ja-was receiving steroids. The patients were studied without
pan) as described previously [3, 4, 19–21]. The carotidwashing out these medications.
artery was scanned bilaterally in the longitudinal andThe HD group consisted of those who were on mainte-
transverse projections. The examination included ap-nance hemodialysis for more than three months. The
proximately 4 cm of the common carotid artery, the ca-HD patients received three to five hours of hemodialysis,
rotid bulb, and 1 cm each of the internal and externalthree times a week, using bicarbonate dialysate. Dialyzer
arteries. The image was focused on the far wall of themembranes were cuprophane (59%), polymethylmetha-
arteries. The site of the most advanced atheroscleroticcrylate (20%), cellulose triacetate (16%), and ethylene
lesion that showed the greatest distance between thevinyl alcohol (5%). The average (SD) dose of dialysis
(Kt/V) was 1.41 0.31. The underlying renal diseases of lumen-intima interface and the media-adventitia inter-
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face was located in both the right and left carotid arteries.
The greatest thickness of intima-media complex was
used for analysis in this study. The intra-observer coeffi-
cient of variation for CA-IMT was 3.6% as previously
described [3].
Blood pressure
Blood pressure was measured with a standard mercury
sphygmomanometer and cuffs, after the subject had rested
in the supine position for at least five minutes. The sys-
tolic and diastolic blood pressure levels were taken as
the points of appearance and disappearance of Korotkoff
sounds, respectively. The average of three measurements
was used for analysis.
Fig. 1. Carotid artery-intima media thickness (CA-IMT) of the ()
healthy, ( ) predialysis and () hemodialysis (HD) groups. Data are
mean  SE. Numbers in each column indicate the number of subjects.Blood sampling and biochemical assays
*P  0.01 vs. healthy control group, **P  0.001 vs. healthy control
Venous blood was taken in the morning after an over- group by Scheffe-type multiple comparison. There was no signifi-
cant difference between the CRF and HD groups except in the 40- tonight fast for at least 12 hours. In hemodialysis patients,
49-year-old range (#P  0.05 vs. CRF group by Scheffe-type multi-blood was taken at least 44 hours after the previous ple comparison).
dialysis session. Plasma glucose was measured by a glu-
cose oxidase method. Total cholesterol was measured by
an enzymatic method. High-density lipoprotein (HDL) RESULTS
cholesterol was determined in the supernatant after pre-
Comparison of CA-IMT among the three groupscipitation of apolipoprotein B-containing lipoproteins
Figure 1 shows CA-IMTs of the three groups. Thewith dextran sulfate and MgCl2. Then, non-HDL choles-
HD group had a significantly greater CA-IMT (0.868 terol was calculated by subtracting HDL cholesterol
0.019 mm, mean  SE, P  0.0001) than the healthyfrom total cholesterol. Other measurements were done
control subjects (0.685  0.010 mm). CA-IMT of theby routine laboratory methods.
CRF group (0.889  0.035 mm, P  0.0001) also was
significantly greater than that of the healthy subjects,Information on smoking
whereas it was not significantly different from CA-IMT
Data on smoking was obtained by a questionnaire, and of the HD group (P  0.821).
a smoking index was calculated as the product of ciga- In age-categorized comparison, the increased CA-IMT
rette number per day and years of smoking history to of the HD group was significant in all age ranges. Simi-
express life-long exposure. larly, the CRF group showed greater CA-IMT than the
healthy control group, although the difference was not
Statistical analysis significant in patients in their forties. When compared
between the HD and CRF groups, CA-IMT did not dif-The results were summarized as mean standard error
fer significantly in the 50 to 59, 60 to 69, and 70 to 79-(SE). Difference between groups was assessed by analy-
year-old age ranges; it differed between the two groupssis of variance (ANOVA), and then post-hoc test was
only in the 40 to 49-year-old range.performed by Scheffe-type multiple comparison. Corre-
lation between two variables was examined by linear Correlation between CA-IMT and other variables
regression analysis. Independent association between
Factors affecting CA-IMT were examined by simple re-variables was evaluated by multiple regression analysis.
gression analysis (Table 2). In the total subjects, CA-IMT
Dummy variables were used for gender (0 for female, correlated positively with age, smoking, and systolic blood
1 for male), chronic renal failure (0 for the absence, 1 for pressure, and negatively with HDL cholesterol. In ad-
the presence of renal failure), and hemodialysis (0 for dition to these factors, CA-IMT correlated with plasma
non-hemodialysis, 1 for hemodialysis). Difference in prev- triglycerides and non-HDL cholesterol levels in the
alence was evaluated by chi-square test. P values less healthy control group.
than 0.05 were taken as statistically significant. All these CA-IMT in the CRF group correlated significantly
analyses were performed using a commercially available with age and smoking, and with systolic blood pressure
software for Windows (StatView 5; SAS Institute Inc., at a borderline significance. Serum creatinine did not
correlate with CA-IMT in this group.Cary, NC, USA) on personal computers.
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Table 3. Multiple regression analysis of factors affecting CA-IMTTable 2. Simple regression analysis of factors
correlating with CA-IMT
Model 1 Model 2 Model 3
Variables Total subjects Healthy CRF Hemodialysis
Age 0.275c 0.270c 0.270c
Male gender 0.016 0.016 0.016Age 0.294d 0.304d 0.436d 0.262d
Serum creatinine 0.072 0.022 0.065 0.253d Smoking index 0.077 0.095b 0.096b
Systolic BP 0.174c 0.081b 0.081bSmoking index 0.134d 0.166c 0.242b 0.095a
Systolic BP 0.211d 0.270d 0.204a 0.018 NonHDL-C 0.036 0.079b 0.079b
HDL-C 0.129c 0.067a 0.067aDiastolic BP 0.044 0.089 0.106 0.031
BMI 0.036 0.036 0.078 0.021 Presence of renal failure — 0.251c 0.245c
Hemodialysis — — 0.008Glucose 0.001 0.032 0.074 0.064
Total cholesterol 0.030 0.013 0.123 0.040 R2 0.151c 0.199c 0.199c
Triglycerides 0.061 0.119b 0.142 0.037 Abbreviations are: BP, blood pressure; HDL-C, high-density lipoprotein cho-
NonHDL-C 0.042 0.143b 0.144 0.056 lesterol; NonHDL-C, non-high-density lipoprotein cholesterol.
HDL-C 0.166d 0.228d 0.069 0.036 a P  0.068, bP  0.05, c P  0.001
Duration of HD — — — 0.017
Abbreviations are: CRF, chronic renal failure; BP, blood pressure; BMI, body
mass index; HDL-C, high-density lipoprotein cholesterol; NonHDL-C, non-high-
density lipoprotein cholesterol; HD, hemodialysis.
a P  0.07–0.08, bP 0.05, c P 0.01, dP  0.001 by simple regression analysis dialysis patients. In addition, the presence of renal fail-
ure, not hemodialysis treatment, showed a significant
impact on the increased CA-IMT independent of age,
gender, blood pressure, smoking and lipid levels. These
In the HD patients, CA-IMT correlated significantly results suggest that it is not hemodialysis per se, but
with age, and with smoking at a borderline significance. chronic renal failure and/or metabolic alterations sec-
Duration of hemodialysis treatment did not correlate ondary to renal failure that promote the vascular change
with CA-IMT. CA-IMT showed not a positive but a neg- in these patients.
ative correlation with serum creatinine concentration in The degree of atherosclerosis can be evaluated from
this group. various aspects such as incidence of death from athero-
sclerotic disease, narrowing of arterial lumen, histologi-Independent factors associated with CA-IMT
cal grading, and stiffening and thickening of arterial wall.
Factors independently associated with CA-IMT were
The report by Lindner et al was the first that pointed out
examined by using multiple regression models in the
the extremely elevated risk of death from cardiovascular
total subjects (Table 3). In the first model including clas-
disease in long-term hemodialysis patients [2], and this
sical risk factors, CA-IMT showed significant and inde-
has been confirmed by a number of subsequent studiespendent association with age, systolic blood pressure and
[1]. Also, the incidence of myocardial infarction [22] andHDL cholesterol. In model 2 containing the presence of
stroke [23] in hemodialysis patients is much higher thanrenal failure as an additional variable, renal failure was
that in the general population. However, these facts doshown as a significant factor associated with CA-IMT inde-
not directly mean that atherosclerosis was acceleratedpendent of the above factors. In the final model (model
by hemodialysis, because subclinical but advanced ath-3) including hemodialysis as an additional variable, the
erosclerosis might have been present before hemodialy-effect of renal failure on CA-IMT remained significant,
sis treatment was initiated. According to Joki et al, 53.8%whereas the association between hemodialysis treatment
of asymptomatic patients starting hemodialysis had sig-and CA-IMT was not significant. In models 2 and 3,
nificant coronary artery stenosis as evidenced by coro-CA-IMT had significant and independent associations
nary angiography [18]. Results of the present study are inwith age, smoking, systolic blood pressure and non-HDL
good agreement with the above report [18], and providecholesterol, whereas the association between CA-IMT
further evidence that advanced atherosclerotic vascularand HDL cholesterol was at a borderline significance.
change is present in patients with chronic renal failure
before starting hemodialysis.
DISCUSSION No previous studies found that duration of hemodialy-
sis treatment correlated significantly with histologicalAtherosclerosis is advanced in patients with chronic
grading [17] or stiffness of arterial wall [5, 6, 11]. Regard-renal failure treated with hemodialysis. Although earlier
ing thickness of arterial wall, some studies found a sig-studies proposed the possibility that atherosclerosis is
nificant positive correlation between CA-IMT and dura-accelerated in long-term maintenance hemodialysis [2],
tion of hemodialysis [11–13], whereas others did not [3,it is not established whether hemodialysis is responsible
14–16]. The present study enrolling 345 hemodialysisfor the advanced atherosclerosis in these patients. The pres-
patients was again unable to demonstrate any significantent study demonstrates that predialysis patients with
association between CA-IMT and duration of hemodial-chronic renal failure had a significantly increased CA-IMT
that was comparable with that of maintenance hemo- ysis treatment by univariate or multivariate analysis. Fur-
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thermore, we found that predialysis patients with chronic cannot rule out a possibility that hemodialysis promotes
atherosclerosis in young patients.renal failure had a significantly increased CA-IMT that
There are a few limitations in the present study. First,was comparable with that of maintenance hemodialysis
the patients were studied while under medications forpatients. These results do not support the previous hy-
hypertension, dyslipidemia, and other metabolic abnor-pothesis that hemodialysis accelerates atherosclerosis
malities associated with renal failure. Therefore, our data[2], but strongly suggest that it is renal failure and/or
might have underestimated the effects of these factorsmetabolic alterations secondary to renal failure that
on CA-IMT. Second, although we showed that chronicpromote atherosclerosis. This concept was further sup-
renal failure was a significant factor associated with in-ported by the results by multiple regression analysis that
creased CA-IMT independent of the classical risk fac-the presence of renal failure, not hemodialysis, was as-
tors, we could not evaluate effects of the non-classicalsociated with CA-IMT independent of other confound-
risk factors, such as parathyroid hormone [3], homocys-ing variables.
teine [37], and C-reactive protein [32, 33], which mightWhat is responsible for the increased risk of athero-
have added to the power of analysis. And finally, wesclerosis in chronic renal failure? Distinct changes can be
measured CA-IMT as a morphological index of athero-detected in some of classical and non-classical risk fac-
sclerosis. Measurement of arterial wall stiffness will pro-tors of atherosclerosis as early as renal function begins to
vide additional information regarding the effects of renaldecline. Previous studies showed lipid and lipoprotein al-
failure and hemodialysis on functional changes of arterialterations [24] and increased serum lipoprotein(a) [Lp(a)]
wall in patients with chronic renal failure.[25] in predialysis patients with chronic renal failure.
In conclusion, we demonstrate that CA-IMT of predi-Also, patients with renal failure have potentially athero-
alysis patients with chronic renal failure is as great asgenic endocrinological abnormalities such as insulin re-
that of patients with maintenance hemodialysis. Thesistance [26] and secondary hyperparathyroidism [27].
presence of renal failure, rather than hemodialysis, wasSecondary hyperparathyroidism was shown to be associ-
a significant factor associated with increased CA-IMT.ated with increased CA-IMT in hemodialysis patients
These results support the concept that advanced athero-[3, 28, 29]. Furthermore, a high plasma concentration of
sclerosis in patients with end-stage renal disease is duehomocysteine [30] has recently been regarded as a strong
not to hemodialysis treatment, but to renal failure and/orrisk factor of atherosclerosis, and it is even higher in renal
metabolic abnormalities secondary to renal failure. Fur-failure [31]. Finally, inflammation or increased serum
ther studies are needed to elucidate the precise mecha-C-reactive protein concentration may be involved in
nism by which renal failure promotes atherosclerosis inatherogenesis in predialysis patients as well as in those
the predialysis stage of renal failure. Also, it would be
treated with hemodialysis [32, 33]. These factors may
better to initiate the management of atherogenic risk
explain the increased risk of atherosclerosis in predialysis factors at an earlier stage of renal disease.
phase of chronic renal failure.
Reprint requests to Tetsuo Shoji, M.D., Ph.D., Department of Me-CA-IMT was comparable between the predialysis and
tabolism, Endocrinology and Molecular Medicine, Osaka City Univer-hemodialysis groups in this study. If chronic renal failure
sity Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka
but not hemodialysis promotes atherosclerosis, the lack 545-8585, Japan.
E-mail: t-shoji@med.osaka-cu.ac.jpof difference in CA-IMT suggests the presence of bene-
ficial effects of hemodialysis. In fact, hemodialysis re-
REFERENCESduces some of the risk factors of atherosclerosis. Body
fluid removal by hemodialysis improves control of blood 1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of car-
diovascular disease in chronic renal disease. Am J Kidney Dis 32pressure. Plasma concentration of Lp(a) decreases fol-
(Suppl):S112–S119, 1998lowing the initiation of hemodialysis [34]. Predialysis pa- 2. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated
tients with renal failure show the atherogenic small- atherosclerosis in prolonged maintenance hemodialysis. N Engl J
Med 290:697–701, 1974dense low-density lipoprotein (LDL) phenotype [35],
3. Kawagishi T, Nishizawa Y, Konishi T, et al: High-resolution
whereas LDL particle size returns to normal in hemo- B-mode ultrasonography in evaluation of atherosclerosis in uremia.
Kidney Int 48:820–826, 1995dialysis patients [36]. These data suggest the existence
4. Shoji T, Kawagishi T, Emoto M, et al: Additive impacts of diabetesof potentially beneficial effects of hemodialysis on ath-
and renal failure on carotid atherosclerosis. Atherosclerosis 153:
erosclerosis. 257–258, 2000
5. London GM, Marchais SJ, Safar ME, et al: Aortic and largeWithin the subjects in the fourth decade of age, a
artery compliance in end-stage renal failure. Kidney Int 37:137–significant increase in CA-IMT was found in the hemodi- 142, 1990
alysis group but not in the predialysis patients. We have 6. Shoji T, Nishizawa Y, Kawagishi T, et al: Intermediate-density
lipoprotein as an independent risk factor for aortic atherosclerosisno clear explanation for this result. It may be a chance
in hemodialysis patients. J Am Soc Nephrol 9:1277–1284, 1998observation because the number of the predialysis pa- 7. O’Leary DH, Polak JF, Kronmal RA, et al: Carotid-artery intima
and media thickness as a risk factor for myocardial infarction andtients in this age category was the smallest, although we
Shoji et al: Atherosclerosis in predialysis patients2192
stroke in older adults. Cardiovascular Health Study Collaborative myocardial infarction in patients on chronic hemodialysis. The
Okinawa Dialysis Study Group. Am J Kidney Dis 36:820–825, 2000Research Group. N Engl J Med 340:14–22, 1999
23. Iseki K, Fukiyama K: Clinical demographics and long-term progno-8. Blacher J, Asmar R, Djane S, et al: Aortic pulse wave velocity as
sis after stroke in patients on chronic haemodialysis. The Okinawaa marker of cardiovascular risk in hypertensive patients. Hypertens
Dialysis Study (OKIDS) Group. Nephrol Dial Transplant 15:1808–33:1111–1117, 1999
1813, 20009. Blacher J, Guerin AP, Pannier B, et al: Impact of aortic stiff-
24. Attman PO, Samuelsson O, Alaupovic P: Lipoprotein metabo-ness on survival in end-stage renal disease. Circulation 99:2434–
lism and renal failure. Am J Kidney Dis 21:573–592, 19932439, 1999
25. Kandoussi A, Cachera C, Pagniez D, et al: Plasma level of lipo-10. Shoji T, Emoto M, Shinohara K, et al: Diabetes mellitus, aortic
protein Lp(a) is high in predialysis or hemodialysis, but not instiffness and cardiovascular mortality in end-stage renal disease. CAPD. Kidney Int 42:424–425, 1992
J Am Soc Nephrol 12:2117–2124, 2001 26. DeFronzo RA, Alvestrand A, Smith D, et al: Insulin resistance
11. Burdick L, Periti M, Salvaggio A, et al: Relation between carotid in uremia. J Clin Invest 67:563–568, 1981
artery atherosclerosis and time on dialysis. A non-invasive study 27. Llach F, Massry SG: On the mechanism of secondary hyperpara-
in vivo. Clin Nephrol 42:121–126, 1994 thyroidism in moderate renal insufficiency. J Clin Endocrinol Metab
12. Sakurabayashi T, Fujimoto M, Takaesu Y, et al: Association 61:601–606, 1985
between plasma homocysteine concentration and carotid athero- 28. Nishizawa Y, Shoji T, Kawagishi T, Morii H: Atherosclerosis in
sclerosis in hemodialysis patients. Jpn Circ J 63:692–696, 1999 uremia: Possible roles of hyperparathyroidism and intermediate
density lipoprotein accumulation. Kidney Int 52(Suppl 62):S90–13. Guz G, Nurhan Ozdemir F, Sezer S, et al: Effect of apolipoprotein
S92, 1997E polymorphism on serum lipid, lipoproteins, and atherosclerosis
29. Shoji T, Nishizawa Y, Kawagishi T, et al: Secondary hyperpara-in hemodialysis patients. Am J Kidney Dis 36:826–836, 2000
thyroidism, decreased hepatic triglyceride lipase, elevated interme-14. Hojs R: Carotid intima-media thickness and plaques in hemodialy-
diate density lipoprotein and atherosclerosis in hemodialysis pa-sis patients. Artif Organs 24:691–695, 2000
tients. Nephron 78:121–122, 199815. Malatino LS, Mallamaci F, Benedetto FA, et al: Hepatocyte
30. Clarke R, Daly L, Robinson K, et al: Hyperhomocystein-growth factor predicts survival and relates to inflammation and
emia: An independent risk factor for vascular disease. N Engl Jintima media thickness in end-stage renal disease. Am J Kidney Med 324:1149–1155, 1991
Dis 36:945–952, 2000 31. Chauveau P, Chadefaux B, Coude M, et al: Increased plasma
16. Fujisawa M, Haramaki R, Miyazaki H, et al: Role of lipoprotein homocysteine concentration in patients with chronic renal failure.
(a) and TGF-beta 1 in atherosclerosis of hemodialysis patients. Miner Electrolyte Metab 18:196–198, 1992
J Am Soc Nephrol 11:1889–1895, 2000 32. Stenvinkel P, Heimburger O, Paultre F, et al: Strong association
17. Vincenti F, Amend WJ, Abele J, et al: The role of hyperten- between malnutrition, inflammation, and atherosclerosis in chronic
sion in hemodialysis-associated atherosclerosis. Am J Med 68:363– renal failure. Kidney Int 55:1899–1911, 1999
369, 1980 33. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation en-
hances cardiovascular risk and mortality in hemodialysis patients.18. Joki N, Hase H, Nakamura R, Yamaguchi T: Onset of coronary
Kidney Int 55:648–658, 1999artery disease prior to initiation of haemodialysis in patients with
34. Kawasaki K: Plasma Lp(a) in patients with chronic renal failure.end-stage renal disease. Nephrol Dial Transplant 12:718–723, 1997
Osaka Shi Igakukai Zasshi 47:285–295, 199819. Hosoi M, Nishizawa Y, Kogawa K, et al: Angiotensin-converting
35. Hirano T, Oi K, Sakai S, et al: High prevalence of small denseenzyme gene polymorphism is associated with carotid arterial wall
LDL in diabetic nephropathy is not directly associated with kidneythickness in non-insulin-dependent diabetic patients. Circulation
damage: A possible role of postprandial lipemia. Atherosclerosis94:704–707, 1996
141:77–85, 199820. Kogawa K, Nishizawa Y, Hosoi M, et al: Effect of polymorphism 36. Oi K, Hirano T, Sakai S, et al: Role of hepatic lipase in intermedi-
of apolipoprotein E and angiotensin-converting enzyme genes on ate-density lipoprotein and small, dense low-density lipoprotein
arterial wall thickness. Diabetes 46:682–687, 1997 formation in hemodialysis patients. Kidney Int 56(Suppl 71):S227–
21. Taniwaki H, Kawagishi T, Emoto M, et al: Correlation between S228, 1999
the intima-media thickness of the carotid artery and aortic pulse- 37. Bostom AG, Shemin D, Verhoef P, et al: Elevated fasting total
wave velocity in patients with type 2 diabetes. Vessel wall proper- plasma homocysteine levels and cardiovascular disease outcomes
ties in type 2 diabetes. Diabetes Care 22:1851–1857, 1999 in maintenance dialysis patients. A prospective study. Arterioscler
Thromb Vasc Biol 17:2554–2558, 199722. Iseki K, Fukiyama K: Long-term prognosis and incidence of acute
